Nvidia, Walmart, Crypto Stocks Lead Major Midday Moves

AI and Semiconductors

• Nvidia — dropped nearly 2%, reversing earlier gains, despite beating expectations for its fiscal third-quarter results and providing stronger-than-expected revenue guidance for the next quarter.
• Palantir Technologies — down nearly 6% as AI-related names declined alongside Nvidia.
• AMD — down 5%.
• Super Micro Computer — down 5%.

Crypto-Linked Stocks

Cryptocurrency-linked assets saw declines as Bitcoin’s value slid further and hopes for interest rate cuts diminished.

• Strategy — a Bitcoin treasury-focused company, lost almost 7%.
• Robinhood Markets — fell about 9%.
• Coinbase — slipped 7%.
• Circle Internet — down approximately 6%.

Pharma and Biotech

• Regeneron — shares climbed 4% after the U.S. Food and Drug Administration approved Eylea HD as a treatment for macular edema following retinal vein occlusion.

Retail

• Walmart — jumped nearly 6% after reporting stronger-than-expected third-quarter earnings. The retail giant posted adjusted earnings per share of 62 cents on $179.5 billion in revenue, surpassing analysts’ forecasts, and raised its full-year sales outlook.

Cybersecurity and Cloud

• Palo Alto Networks — dipped more than 6% following its announcement to acquire cloud management specialist Chronosphere for $3.35 billion, despite delivering fiscal first-quarter earnings that exceeded Wall Street expectations.

Beauty and Wellness

• Oddity — surged 11% on better-than-anticipated third-quarter results and an upgraded earnings forecast. Adjusted earnings reached 40 cents per share on $148 million in revenue, topping analyst expectations.

Engineering and Construction

• Jacobs Solutions — fell 9% despite outperforming earnings estimates for the fiscal fourth quarter and offering a strong outlook for fiscal 2026.

Healthcare

• Solventum — rose 4% after announcing the purchase of Acera Surgical for $725 million, moving into regenerative wound care markets.

Consumer and Specialty Retail

• Bath & Body Works — tumbled over 25% as third-quarter results missed analyst predictions, with adjusted earnings of 35 cents per share and $1.59 billion in revenue, below consensus forecasts.